Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (34)

2024

  1. Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  2. Tissue-specific early and late activated lymphocytes immunophenotype in chronic rhinosinusitis with nasal polyps

    International Forum of Allergy and Rhinology

2023

  1. Tissue-specific Activated Regulatory Lymphocytes Immunophenotype in Chronic Rhinosinusitis with Nasal Polyps

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 337-340

  2. Transcriptional analysis of nasal polyps fibroblasts reveals a new source of pro-inflammatory signaling in CRSwNP*

    Rhinology, Vol. 61, Núm. 2, pp. 180-189

2022

  1. Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

2021

  1. Role of leptin in non-alcoholic fatty liver disease

    Biomedicines, Vol. 9, Núm. 7

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  2. Molecular inflammation and oxidative stress are shared mechanisms involved in both myocardial infarction and periodontitis

    Journal of Periodontal Research, Vol. 55, Núm. 4, pp. 519-528

  3. Sequential Changes of NLRP3 Inflammasome Activation in Sepsis and its Relationship With Death

    Shock (Augusta, Ga.), Vol. 54, Núm. 3, pp. 294-300

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

2018

  1. Body fat and metabolic age as indicators of inflammation and cardiovascular risk

    European Journal of Preventive Cardiology

2017

  1. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder

    Pharmacological Research, Vol. 121, pp. 114-121

  2. Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 5, pp. 269-275

2016

  1. Gene Expression Profile in Major Depressive Disorder Shows Reduced Mitochondrial Biogenesis

    CNS Neuroscience and Therapeutics

  2. Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome

    Molecular Neurobiology, Vol. 53, Núm. 7, pp. 4874-4882

2015

  1. Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 11, pp. 2535-2553

2014

  1. Clinical symptoms in fibromyalgia are associated to overweight and lipid profile

    Rheumatology International, Vol. 34, Núm. 3, pp. 419-422

  2. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder

    Brain, Behavior, and Immunity, Vol. 36, pp. 111-117

2012

  1. Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients

    Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 341-345

2011

  1. Coenzyme Q10: A novel therapeutic approach for Fibromyalgia? Case series with 5 patients

    Mitochondrion, Vol. 11, Núm. 4, pp. 623-625